Retatrutide vs Tirzepatide: What's the Difference?

If you've been following the latest developments in weight loss medications, you've probably heard about tirzepatide—the dual-action medication that's been making headlines. But there's a newer player entering the conversation: retatrutide. While tirzepatide is already helping thousands of people reach their weight loss goals, retatrutide is still in clinical trials and showing even more dramatic results. So what's the difference, and what do you need to know?

Understanding How These Medications Work

Both retatrutide and tirzepatide belong to a new generation of weight loss medications that work by mimicking hormones your body naturally produces. But they don't work in exactly the same way.

Tirzepatide: The Dual-Action Approach

Tirzepatide, sold under the brand names Mounjaro and Zepbound, works on two hormone receptors: GLP-1 and GIP. GLP-1 helps regulate blood sugar and reduces appetite, while GIP works alongside it to enhance these effects. This dual action is why tirzepatide has shown such impressive results in clinical trials.

People taking tirzepatide in clinical studies lost an average of 15-21% of their body weight over 72 weeks, depending on the dose. It's currently FDA-approved for both type 2 diabetes management and chronic weight management.

Retatrutide: The Triple-Action Newcomer

Retatrutide takes things a step further by targeting three hormone receptors: GLP-1, GIP, and glucagon. That third receptor—glucagon—helps your body burn more energy and may increase metabolic rate. This triple action is what researchers believe leads to retatrutide's even more dramatic weight loss results.

In phase 2 clinical trials, participants taking the highest dose of retatrutide lost an average of 24% of their body weight over 48 weeks. That's significantly more than what we've seen with tirzepatide or semaglutide. However, it's important to remember that retatrutide is still in clinical trials and not yet FDA-approved.

Comparing Effectiveness

When it comes to weight loss, both medications are highly effective—but retatrutide appears to have an edge based on early data.

Tirzepatide has proven itself in large, rigorous clinical trials with thousands of participants. The results are consistent and well-documented. People typically see gradual, steady weight loss when combined with lifestyle modifications.

Retatrutide's trial data shows even greater weight loss potential, with some participants losing more than a quarter of their body weight. But these are still early-stage trials with fewer participants, and we won't know the full picture until larger phase 3 trials are complete.

What About Side Effects?

Both medications share similar side effect profiles, which makes sense given that they work on some of the same hormone pathways.

Common side effects for both include nausea, diarrhea, constipation, vomiting, and decreased appetite. These effects are typically most noticeable when starting the medication or increasing the dose, and they often improve over time.

Because retatrutide is still in trials, we're still learning about its complete safety profile. Some trial participants reported more gastrointestinal side effects with retatrutide compared to other medications, but this could be related to the higher doses being tested.

Availability and Cost Considerations

This is where the biggest practical difference comes in.

Tirzepatide is available now. You can get a prescription from your healthcare provider today, either through brand-name options or compounded versions. Many people are already using it successfully for weight loss and diabetes management.

Retatrutide is not yet available outside of clinical trials. It's still undergoing the rigorous testing required for FDA approval, which likely means it won't be available to the general public until 2026 or later.

When retatrutide does become available, it will likely be expensive—just as tirzepatide and semaglutide were at launch. Compounded versions may eventually become available, but that would be years down the line.

Gender-Specific Considerations

Both medications have been studied in both men and women, though women make up a larger percentage of participants in weight loss trials overall.

Women may experience slightly different side effect profiles, particularly regarding nausea, which tends to be reported more frequently by women. Hormonal fluctuations throughout the menstrual cycle can also affect how these medications feel, though they don't impact their effectiveness.

Men often see faster initial weight loss on these medications, partly due to typically higher starting weights and muscle mass. However, by the end of treatment, the percentage of weight lost tends to be similar between genders.

If you're pregnant, planning to become pregnant, or breastfeeding, neither medication is recommended. Women of childbearing age should discuss contraception with their healthcare provider, as these medications should be stopped at least two months before trying to conceive.

Which One Is Right for You?

Right now, this isn't really a choice you need to make—because retatrutide isn't available yet.

If you're looking for effective weight loss support today, tirzepatide is an excellent, proven option. It has years of clinical data behind it, it's currently available, and it's helping thousands of people achieve meaningful weight loss.

When retatrutide eventually becomes available, it may offer even greater weight loss potential. But we'll need to see more data on its long-term safety and effectiveness before it becomes a standard treatment option.

The most important factor isn't which medication is theoretically better—it's finding a treatment plan that works for your individual needs, health history, and goals. That's a conversation to have with a qualified healthcare provider who can evaluate your specific situation.

From the Ozari Care Team

Whether you're considering tirzepatide now or keeping an eye on emerging options like retatrutide, remember that medication is just one part of successful weight management. We've seen the best results in patients who combine their medication with sustainable nutrition changes and regular movement they actually enjoy. Think of these medications as powerful tools that work best when paired with lifestyle support—not magic solutions on their own.

Ready to Start Your Weight Loss Journey?

At Ozari Health, we offer compounded semaglutide and tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026